NCT01813357View on ClinicalTrials.gov

Does Rosuvastatin Delay Progression of Atherosclerosis in HIV

PHASE4CompletedINTERVENTIONAL

Enrollment

84

Participants

Timeline

Start Date

July 2, 2013

Primary Completion Date

May 17, 2018

Study Completion Date

November 1, 2018

Conditions

HIVCardiovascular Disease

Interventions

DRUG

Rosuvastatin

encapsulated tablet 20mg daily

OTHER

Placebo

Placebo arm included to maintain blinding

Trial Locations (2)

3004

Alfred Hospital, Melbourne

Unknown

Hospitaux Universitaires de Geneve, Geneva

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayside Health

OTHER_GOV